BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Alfacell

About Alfacell

Alfacell is a biopharmaceutical company focused on the discovery, development and commercialization of novel ribonucleases (RNases). Their mission is to develop new therapeutics from their novel ribonuclease technology platform for the treatment of cancer, infectious diseases and other life threatening conditions, thus offering new horizons of hope for patients and physicians.

 

Pipeline:

Onconase (ranpirnase) --a Ribonuclease anti-cancer drug

Oncanase data:

Animal studies have shown that using ONCONASE alone effectively kills cancer cells with manageable toxicity. ONCONASE improves radiation response and enhances the efficacy of commonly used chemotherapeutic agents (such as cisplatin and carboplatin) in human NSCLC xenografts of nude mice.





More on Alfacell
:

Home Page

Key Statistics fo Alfacell

Basic Chart for Alfacell

Analyst Opinion

Analysts Estimates

 
Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com